EMEA (Europe, Middle East and Africa) Glucose Dependent Insulinotropic Receptor Market Report 2017

December 2017 | 114 pages | ID: E516C6A905EEN
QYResearch

Abstracts

In this report, the EMEA Glucose Dependent Insulinotropic Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Glucose Dependent Insulinotropic Receptor for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Glucose Dependent Insulinotropic Receptor market competition by top manufacturers/players, with Glucose Dependent Insulinotropic Receptor sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amgen Inc
• Arena Pharmaceuticals Inc
• CymaBay Therapeutics Inc
• Dong-A Socio Holdings Co Ltd
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline Plc
• Hyundai Pharmaceutical Co Ltd
• Kowa Co Ltd
• Merck & Co Inc
• Novartis AG
• Taisho Pharmaceutical Holdings Co Ltd
• Takeda Pharmaceutical Co Ltd
• Yuhan Corp

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• DA-1241
• GSK-2041706
• HD-0471042
• HD-0471953
• HOB-047
• MBX-2982
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Type 2 Diabetes
• Obesity
• Chronic Obstructive Pulmonary Disease (COPD)
• Dyslipidemia
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Glucose Dependent Insulinotropic Receptor Market Report 2017

1 GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR OVERVIEW

1.1 Product Overview and Scope of Glucose Dependent Insulinotropic Receptor
1.2 Classification of Glucose Dependent Insulinotropic Receptor
  1.2.1 EMEA Glucose Dependent Insulinotropic Receptor Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Glucose Dependent Insulinotropic Receptor Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 DA-1241
  1.2.4 GSK-2041706
  1.2.5 HD-0471042
  1.2.6 HD-0471953
  1.2.7 HOB-047
  1.2.8 MBX-2982
  1.2.9 Others
1.3 EMEA Glucose Dependent Insulinotropic Receptor Market by Application/End Users
  1.3.1 EMEA Glucose Dependent Insulinotropic Receptor Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Type 2 Diabetes
  1.3.3 Obesity
  1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
  1.3.5 Dyslipidemia
  1.3.6 Others
1.4 EMEA Glucose Dependent Insulinotropic Receptor Market by Region
  1.4.1 EMEA Glucose Dependent Insulinotropic Receptor Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Glucose Dependent Insulinotropic Receptor (2012-2022)
  1.5.1 EMEA Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2012-2022)

2 EMEA GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Glucose Dependent Insulinotropic Receptor Market Competition by Players/Manufacturers
  2.1.1 EMEA Glucose Dependent Insulinotropic Receptor Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Glucose Dependent Insulinotropic Receptor Sale Price by Players (2012-2017)
2.2 EMEA Glucose Dependent Insulinotropic Receptor (Volume and Value) by Type/Product Category
  2.2.1 EMEA Glucose Dependent Insulinotropic Receptor Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Glucose Dependent Insulinotropic Receptor Sale Price by Type (2012-2017)
2.3 EMEA Glucose Dependent Insulinotropic Receptor (Volume) by Application
2.4 EMEA Glucose Dependent Insulinotropic Receptor (Volume and Value) by Region
  2.4.1 EMEA Glucose Dependent Insulinotropic Receptor Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Glucose Dependent Insulinotropic Receptor Sales Price by Region (2012-2017)

3 EUROPE GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Glucose Dependent Insulinotropic Receptor Sales and Value (2012-2017)
  3.1.1 Europe Glucose Dependent Insulinotropic Receptor Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2012-2017)
3.2 Europe Glucose Dependent Insulinotropic Receptor Sales and Market Share by Type
3.3 Europe Glucose Dependent Insulinotropic Receptor Sales and Market Share by Application
3.4 Europe Glucose Dependent Insulinotropic Receptor Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Glucose Dependent Insulinotropic Receptor Sales Volume by Countries (2012-2017)
  3.4.2 Europe Glucose Dependent Insulinotropic Receptor Revenue by Countries (2012-2017)
  3.4.3 Germany Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  3.4.4 France Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  3.4.5 UK Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  3.4.6 Russia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  3.4.7 Italy Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)

4 MIDDLE EAST GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Glucose Dependent Insulinotropic Receptor Sales and Value (2012-2017)
  4.1.1 Middle East Glucose Dependent Insulinotropic Receptor Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2012-2017)
4.2 Middle East Glucose Dependent Insulinotropic Receptor Sales and Market Share by Type
4.3 Middle East Glucose Dependent Insulinotropic Receptor Sales and Market Share by Application
4.4 Middle East Glucose Dependent Insulinotropic Receptor Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Glucose Dependent Insulinotropic Receptor Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Glucose Dependent Insulinotropic Receptor Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  4.4.4 Israel Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  4.4.5 UAE Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  4.4.6 Iran Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)

5 AFRICA GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Glucose Dependent Insulinotropic Receptor Sales and Value (2012-2017)
  5.1.1 Africa Glucose Dependent Insulinotropic Receptor Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2012-2017)
5.2 Africa Glucose Dependent Insulinotropic Receptor Sales and Market Share by Type
5.3 Africa Glucose Dependent Insulinotropic Receptor Sales and Market Share by Application
5.4 Africa Glucose Dependent Insulinotropic Receptor Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Glucose Dependent Insulinotropic Receptor Sales Volume by Countries (2012-2017)
  5.4.2 Africa Glucose Dependent Insulinotropic Receptor Revenue by Countries (2012-2017)
  5.4.3 South Africa Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2012-2017)

6 EMEA GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Amgen Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Arena Pharmaceuticals Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CymaBay Therapeutics Inc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Dong-A Socio Holdings Co Ltd
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 F. Hoffmann-La Roche Ltd
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline Plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Hyundai Pharmaceutical Co Ltd
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Kowa Co Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Merck & Co Inc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Novartis AG
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Glucose Dependent Insulinotropic Receptor Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis AG Glucose Dependent Insulinotropic Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Taisho Pharmaceutical Holdings Co Ltd
6.12 Takeda Pharmaceutical Co Ltd
6.13 Yuhan Corp

7 GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR MANUFACTURING COST ANALYSIS

7.1 Glucose Dependent Insulinotropic Receptor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glucose Dependent Insulinotropic Receptor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Glucose Dependent Insulinotropic Receptor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glucose Dependent Insulinotropic Receptor Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR MARKET FORECAST (2017-2022)

11.1 EMEA Glucose Dependent Insulinotropic Receptor Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Glucose Dependent Insulinotropic Receptor Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Glucose Dependent Insulinotropic Receptor Price and Trend Forecast (2017-2022)
11.2 EMEA Glucose Dependent Insulinotropic Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Glucose Dependent Insulinotropic Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Glucose Dependent Insulinotropic Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Glucose Dependent Insulinotropic Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Glucose Dependent Insulinotropic Receptor Sales Forecast by Type (2017-2022)
11.7 EMEA Glucose Dependent Insulinotropic Receptor Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Glucose Dependent Insulinotropic Receptor
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Volume Market Share by Type (Product Category) in 2016
Figure DA-1241 Product Picture
Figure GSK-2041706 Product Picture
Figure HD-0471042 Product Picture
Figure HD-0471953 Product Picture
Figure HOB-047 Product Picture
Figure MBX-2982 Product Picture
Figure Others Product Picture
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Glucose Dependent Insulinotropic Receptor by Application in 2016
Figure Type 2 Diabetes Examples
Table Key Downstream Customer in Type 2 Diabetes
Figure Obesity Examples
Table Key Downstream Customer in Obesity
Figure Chronic Obstructive Pulmonary Disease (COPD) Examples
Table Key Downstream Customer in Chronic Obstructive Pulmonary Disease (COPD)
Figure Dyslipidemia Examples
Table Key Downstream Customer in Dyslipidemia
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Glucose Dependent Insulinotropic Receptor Market Size (Million USD) by Region (2012-2022)
Figure Europe Glucose Dependent Insulinotropic Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Glucose Dependent Insulinotropic Receptor Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Glucose Dependent Insulinotropic Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Glucose Dependent Insulinotropic Receptor Revenue (Million USD) Status and Forecast by Countries
Figure Africa Glucose Dependent Insulinotropic Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Glucose Dependent Insulinotropic Receptor Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Volume and Growth Rate (2012-2022)
Figure EMEA Glucose Dependent Insulinotropic Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Glucose Dependent Insulinotropic Receptor Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales Share by Players (2012-2017)
Figure 2016 Glucose Dependent Insulinotropic Receptor Sales Share by Players
Figure 2017 Glucose Dependent Insulinotropic Receptor Sales Share by Players
Figure EMEA Glucose Dependent Insulinotropic Receptor Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Revenue (Million USD) by Players (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Revenue Share by Players (2012-2017)
Table 2016 EMEA Glucose Dependent Insulinotropic Receptor Revenue Share by Players
Table 2017 EMEA Glucose Dependent Insulinotropic Receptor Revenue Share by Players
Table EMEA Glucose Dependent Insulinotropic Receptor Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales Share by Type (2012-2017)
Figure Sales Market Share of Glucose Dependent Insulinotropic Receptor by Type (2012-2017)
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Glucose Dependent Insulinotropic Receptor by Type in 2016
Table EMEA Glucose Dependent Insulinotropic Receptor Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales Share by Application (2012-2017)
Figure Sales Market Share of Glucose Dependent Insulinotropic Receptor by Application (2012-2017)
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Market Share by Application in 2016
Table EMEA Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales Share by Region (2012-2017)
Figure Sales Market Share of Glucose Dependent Insulinotropic Receptor by Region (2012-2017)
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Market Share in 2016
Table EMEA Glucose Dependent Insulinotropic Receptor Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Glucose Dependent Insulinotropic Receptor Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Glucose Dependent Insulinotropic Receptor by Region (2012-2017)
Figure EMEA Glucose Dependent Insulinotropic Receptor Revenue Market Share Regions in 2016
Table EMEA Glucose Dependent Insulinotropic Receptor Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2012-2017)
Table Europe Glucose Dependent Insulinotropic Receptor Sales (K Pcs) by Type (2012-2017)
Table Europe Glucose Dependent Insulinotropic Receptor Market Share by Type (2012-2017)
Figure Europe Glucose Dependent Insulinotropic Receptor Market Share by Type in 2016
Table Europe Glucose Dependent Insulinotropic Receptor Sales (K Pcs) by Application (2012-2017)
Table Europe Glucose Dependent Insulinotropic Receptor Market Share by Application (2012-2017)
Figure Europe Glucose Dependent Insulinotropic Receptor Market Share by Application in 2016
Table Europe Glucose Dependent Insulinotropic Receptor Sales (K Pcs) by Countries (2012-2017)
Table Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2012-2017)
Figure Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2012-2017)
Figure Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries in 2016
Table Europe Glucose Dependent Insulinotropic Receptor Revenue (Million USD) by Countries (2012-2017)
Table Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2012-2017)
Figure Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2012-2017)
Figure Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries in 2016
Figure Germany Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Glucose Dependent Insulinotropic Receptor Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Glucose Dependent Insulinotropic Receptor Sales (K Pcs) by Type (2012-2017)
Table Middle East Glucose Dependent Insulinotropic Receptor Market Share by Type (2012-2017)
Figure Middle East Glucose Dependent Insulinotropic Receptor Market Share by Type (2012-2017)
Table Middle East Glucose Dependent Insulinotropic Receptor Sales (K Pcs) by Applications (2012-2017)
Table Middle East Glucose Dependent Insulinotropic Receptor Market Share by Applications (2012-2017)
Figure Middle East Glucose Dependent Insulinotropic Receptor Sales Market Share by Application in 2016
Table Middle East Glucose Dependent Insulinotropic Receptor Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Glucose Dependent Insulinotropic Receptor Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Glucose Dependent Insulinotropic Receptor Sales Volume Market Share by Countries in 2016
Table Middle East Glucose Dependent Insulinotropic Receptor Revenue (Million USD) by Countries (2012-2017)
Table Middle East Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2012-2017)
Figure Middle East Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2012-2017)
Figure Middle East Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries in 2016
Figure Saudi Arabia Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Glucose Dependent Insulinotropic Receptor Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Glucose Dependent Insulinotropic Receptor Sales (K Pcs) by Type (2012-2017)
Table Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2012-2017)
Figure Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2012-2017)
Figure Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Type in 2016
Table Africa Glucose Dependent Insulinotropic Receptor Sales (K Pcs) by Application (2012-2017)
Table Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2012-2017)
Figure Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2012-2017)
Table Africa Glucose Dependent Insulinotropic Receptor Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2012-2017)
Figure Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2012-2017)
Figure Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries in 2016
Table Africa Glucose Dependent Insulinotropic Receptor Revenue (Million USD) by Countries (2012-2017)
Table Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2012-2017)
Figure Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2012-2017)
Figure Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries in 2016
Figure South Africa Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Table Amgen Inc Glucose Dependent Insulinotropic Receptor Basic Information List
Table Amgen Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amgen Inc Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure Amgen Inc Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Basic Information List
Table Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Basic Information List
Table CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Basic Information List
Table Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Basic Information List
Table F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Basic Information List
Table GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Basic Information List
Table Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Basic Information List
Table Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table Merck & Co Inc Glucose Dependent Insulinotropic Receptor Basic Information List
Table Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure Merck & Co Inc Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Glucose Dependent Insulinotropic Receptor Basic Information List
Table Novartis AG Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis AG Glucose Dependent Insulinotropic Receptor Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Glucose Dependent Insulinotropic Receptor Revenue Market Share in EMEA (2012-2017)
Table Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Basic Information List
Table Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Basic Information List
Table Yuhan Corp Glucose Dependent Insulinotropic Receptor Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucose Dependent Insulinotropic Receptor
Figure Manufacturing Process Analysis of Glucose Dependent Insulinotropic Receptor
Figure Glucose Dependent Insulinotropic Receptor Industrial Chain Analysis
Table Raw Materials Sources of Glucose Dependent Insulinotropic Receptor Major Manufacturers in 2016
Table Major Buyers of Glucose Dependent Insulinotropic Receptor
Table Distributors/Traders List
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Glucose Dependent Insulinotropic Receptor Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by Region (2017-2022)
Table EMEA Glucose Dependent Insulinotropic Receptor Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Glucose Dependent Insulinotropic Receptor Revenue Market Share Forecast by Region (2017-2022)
Table Europe Glucose Dependent Insulinotropic Receptor Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by Countries (2017-2022)
Table Europe Glucose Dependent Insulinotropic Receptor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Glucose Dependent Insulinotropic Receptor Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Glucose Dependent Insulinotropic Receptor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Glucose Dependent Insulinotropic Receptor Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Glucose Dependent Insulinotropic Receptor Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by Countries (2017-2022)
Table Africa Glucose Dependent Insulinotropic Receptor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by Type (2017-2022)
Table EMEA Glucose Dependent Insulinotropic Receptor Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources